Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Current Deferred Tax Assets: 2014-2015

Historic Current Deferred Tax Assets for Enanta Pharmaceuticals (ENTA) over the last 2 years, with Sep 2015 value amounting to $1.4 million.

  • Enanta Pharmaceuticals' Current Deferred Tax Assets fell 34.72% to $1.1 million in Q2 2016 from the same period last year, while for Jun 2016 it was $1.1 million, marking a year-over-year decrease of 34.72%. This contributed to the annual value of $1.4 million for FY2015, which is 86.99% down from last year.
  • According to the latest figures from FY2015, Enanta Pharmaceuticals' Current Deferred Tax Assets is $1.4 million, which was down 86.99% from $11.1 million recorded in FY2014.
  • In the past 5 years, Enanta Pharmaceuticals' Current Deferred Tax Assets registered a high of $11.1 million during FY2014, and its lowest value of $1.4 million during FY2015.
  • Moreover, its 2-year median value for Current Deferred Tax Assets was $6.3 million (2014), whereas its average is $6.3 million.
  • Data for Enanta Pharmaceuticals' Current Deferred Tax Assets shows a maximum YoY slumped of 86.99% (in 2015) over the last 5 years.
  • Over the past 2 years, Enanta Pharmaceuticals' Current Deferred Tax Assets (Yearly) stood at $11.1 million in 2014, then slumped by 86.99% to $1.4 million in 2015.